A Phase 2 Study of Topical KB105 for the Treatment of TGM1-deficient Autosomal Recessive Congenital Ichthyosis (ARCI)
Condition:   Autosomal Recessive Ichthyosis Interventions:   Biological: KB105;   Other: Placebo Sponsor:   Krystal Biotech, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2023 Category: Research Source Type: clinical trials

Quality of Life in Middle-aged and Older Patients With Congenital Ichthyosis
Condition:   Congenital Ichthyosis Intervention:   Other: Qualitative interview Sponsor:   Maastricht University Medical Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 9, 2022 Category: Research Source Type: clinical trials